LALaura Arellano-García

Laura Arellano-García

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Arellano-García has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Iñaki Milton-Laskibar

    Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain

    10 shared publications
  • Maria Puy Portillo

    Nutrition and Obesity Group, Department of Nutrition and Food Science, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, Vitoria, Spain

    10 shared publications
  • Jose Alfredo Martinez

    Precision Nutrition and Cardiometabolic Health, IMDEA-Food Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI) UAM+CSIC, 28049 Madrid, Spain

    4 shared publications
  • Saioa Gómez-Zorita

    Nutrition and Obesity Group, Department of Nutrition and Food Science, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, Alava, Spain

    4 shared publications
  • Jenifer Trepiana

    Nutrition and Obesity Group, Department of Nutrition and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Centre, 01006 Vitoria, Spain

    3 shared publications
  • Alfredo Fernández-Quintela

    Nutrition and Obesity Group, Department of Nutrition and Food Science, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain

    2 shared publications

Latest Publications

  • Open Access

    Effects of Bacterial-Derived Extracellular Vesicles in Rodent Models of Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease and Insulin Resistance/type 2 Diabetes. A Systematic Review

    by Laura Arellano-García, Iñaki Milton-Laskibar, María Puy Portillo, Saioa Gomez-Zorita

    Obesity, metabolic-associated steatotic liver disease (MASLD) and insulin resistance/type II diabetes (IR/T2D) share gut microbiota dysbiosis as an etiological factor. Bacteria-derived extracellular vesicles (EVs) have emerged as a promising strategy to modulate gut microbiota composition. To systematically review preclinical in vivo evidence on the effects of bacterial-derived EVs in obesity, MASLD and IR/T2D in rats and mice. Following PRISMA guidelines (PROSPERO registration CRD420261293767), a systematic search was conducted in PubMed/Medline, Web of Science, Scopus and EMBASE® from inception until January 2026 for controlled in vivo studies in mice and rats. Nine studies met inclusion criteria, all of which were conducted in dietary mice models; no eligible rat studies, or genetically-induced models were identified. EVs administration generally reduced body and adipose tissue weight, hepatic lipid accumulation, improved glycaemic control, and modulated gut microbiota composition. Bacterial EVs show promise for preventing and treating obesity-related metabolic disorders, although evidence remains limited and heterogeneous.

  • Open Access

    The Gut–Brain Axis in Obesity: Mechanisms, Development, and Therapeutic Perspectives

    by Laura Arellano-García, María P. Portillo, Anna Hadjihambi, J. Alfredo Martínez, Iñaki Milton-Laskibar

    Purpose of review: This narrative review analyses the implication of obesity-associated gut microbiota dysbiosis, as well as the associated impairments in gut-brain axis communication, in the onset and development of this chronic metabolic disease. Recent findings: Gut microbiota dysbiosis, which is a common feature in individuals with obesity, is considered among the factors leading to its development. In fact, dietary habits not only modulate the composition of gut microbiota, but also the release of microbe-derived metabolites such as SCFAs, which in turn participate in the gut-brain axis communication. Interestingly, the approaches often used for obesity management, including lifestyle modification-based interventions, pharmacotherapy or the usage of bioactives (such as phenolic compounds or probiotics) have also been shown to restore the impairments in gut-brain axis communication associated to this disease. In this regard, the recovery of gut microbiota eubiosis and improvement of the intestinal barrier function, as well as the modulation of microbial metabolite production, have been described as potential underlying mechanisms of action. Summary: The review highlights the importance of the gut-brain axis in obesity, both in the development as well as the management of this chronic metabolic disease. However, further research is warranted in order to corroborate the current findings and to better elucidate the mechanisms underlying this complex signalling network. Doing so, valuable information that will pave the way for the development of more specific and effective obesity treatments may be obtained.


  • Open Access

    Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet

    by N.C.O. Melo, A. Cuevas-Sierra, A. Casillas-Fikentscher, L. Arellano-Garcia, M.P. Portillo, I. Milton-Laskibar, J.A. Martinez

    The consumption of a high-fat high-fructose diet partly resemble the western dietary patterns, which is closely associated with excessive body adiposity and metabolic disorders, such as obesity and type 2 diabetes. Moreover, this unhealthy regime produces unfavourable changes on the faecal microbiota, potentially interfering with microorganisms postbiotic function, such as spermidine, a natural polyamine that has been involved in the control of weight gain. The study aimed to analyse the repercussions of spermidine supplementation on somatic measurements, metabolic markers, and the faecal microbiota profile of rats fed a diet rich in fat and fructose. Indeed, Wistar males with oral administration of spermidine (20 mg/kg/day) for 6 weeks were evaluated for food and energy intake, biochemical markers, and faecal microbiota signatures. The daily use of spermidine decreased weight gain (), reduced feed efficiency (), and attenuated visceral fat deposition (), although no effect on energy intake, hepatic weight, triglyceride and glucose index and atherogenic indexes. Similarly, the consumption of spermidine partially restored the presence of microbial species, notably Akkermansia muciniphila. Elevated concentrations of this species were linked to a decrease in triglycerides (), indicating that the supplementation of spermidine might contribute to managing energy fuel homeostasis in association with an obesogenic diet.


  • Isorhamnetin: Current knowledge and potential benefits for disease management

    by S. Gomez-Zorita, J. Trepiana, I. Milton-Laskibar, M. T. Macarulla, I. Eseberri, L. Arellano-Garcia, R. Merino-Valdeolmillos, I. Alisdair McGeoch, A. Fernandez-Quintela, M. P. Portillo


  • Open Access

    Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic

    by L. Arellano-García, Maria Teresa Macarulla, Amanda Cuevas-Sierra, José Alfredo Martínez, Maria Puy Portillo, Iñaki Milton-Laskibar

    Insulin resistance and type 2 diabetes are obesity-related health alterations, featuring an ever-increasing prevalence.


  • Open Access

    Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats

    by Laura Arellano-García, Jenifer Trepiana, J. Alfredo Martínez, María P. Portillo, Iñaki Milton-Laskibar

    Oxidative stress and inflammation are well-known triggers of NAFLD onset and progression. The aim of this study is to compare the potential benefits of a viable probiotic (Lactobacillus rhamnosus GG) and its parabiotic (heat-inactivated) on oxidative stress, inflammation, DNA damage and cell death pathways in the liver of rats featuring diet-induced NAFLD. The consumption of the steatotic diet led to increased final body and liver weights, higher hepatic triacylglycerol content, altered serum transaminase levels and enhanced oxidative and inflammatory status. Administration of the probiotic and the parabiotic partially prevented the body weight increase induced by the steatotic diet, whereas the probiotic caused more effective decreasing hepatic triglyceride content. Sharp but nonstatistically significant decreases in serum transaminase levels were also observed for both treatments. The reduction in antioxidant enzyme activities found in the nontreated animals fed the steatotic diet was partially prevented by both treatments (GPx activity). Similarly, the reductions in nonenzymatic antioxidant protection (GSH content) and total antioxidant capacity (ORAC) found in the nontreated rats were restored by the administration of both treatments. These results show that both viable and heat-inactivated Lactobacillus rhamnosus GG administration partially prevent steatotic diet-induced liver oxidative stress and inflammation induced in rats.


  • Open Access

    Potential usefulness of Mediterranean diet polyphenols against COVID-19-induced inflammation: a review of the current knowledge

    by Iñaki Milton-Laskibar, Jenifer Trepiana, María Teresa Macarulla, Saioa Gómez-Zorita, Laura Arellano-García, Alfredo Fernández-Quintela, María P. Portillo

    The Mediterranean diet is a dietary pattern typical of the populations living in the Mediterranean basin during the 50s-60s of the last century. This diet has demonstrated beneficial effects in the prevention of several pathologies such as cardiovascular diseases, metabolic syndrome, or several cancer types, at least in part, due to its antioxidant compounds. Since the COVID-19 pandemic started, different authors have been studying the effects of certain dietary habits on the presence of COVID-19 and its severity, and the Mediterranean diet is one of them. This review gathers data from studies supporting the potential usefulness of the main phenolic compounds present in the Mediterranean diet, based on their antioxidant and anti-inflammatory effects, as preventive/therapeutic agents against COVID-19. The current evidence supports the potential benefits that hydroxytyrosol, resveratrol, flavonols such as quercetin, flavanols like catechins, and flavanones on the order of naringenin could have on COVID-19. This is due to the increase in the synthesis and translocations of Nrf-2, which increases the activity of antioxidant enzymes and thus reduces ROS production, the scavenging of free radicals, and the suppression of the activity of MMP-9, which is involved in the cytokine storm, and the inhibition of NF-κB.


  • Open Access

    Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models

    by Laura Arellano-García, María P. Portillo, J. Alfredo Martínez, Iñaki Milton-Laskibar

    The present review aims at analyzing the current evidence regarding probiotic administration for non-alcoholic fatty liver disease (NAFLD) management. Additionally, the involved mechanisms of action modulated by probiotic administration, as well as the eventual limitations of this therapeutic approach and potential alternatives, are discussed. Preclinical studies have demonstrated that the administration of single-strain probiotics and probiotic mixtures effectively prevents diet-induced NAFLD. In both cases, the magnitude of the described effects, as well as the involved mechanisms of action, are comparable, including reduced liver lipid accumulation (due to lipogenesis downregulation and fatty acid oxidation upregulation), recovery of gut microbiota composition and enhanced intestinal integrity. Similar results have also been reported in clinical trials, where the administration of probiotics proved to be effective in the treatment of NAFLD in patients featuring this liver condition. In this case, information regarding the mechanisms of action underlying probiotics-mediated hepatoprotective effects is scarcer (mainly due to the difficulty of liver sample collection). Since probiotics administration represents an increased risk of infection in vulnerable subjects, much attention has been paid to parabiotics and postbiotics, which seem to be effective in the management of several metabolic diseases, and thus represent a suitable alternative to probiotic usage.


  • Open Access

    An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity

    by Saioa Gómez-Zorita, Iñaki Milton-Laskibar, Laura García-Arellano, Marcela González, María P. Portillo

    The present review is aimed at analysing the current evidence concerning the potential modulation of obesity and/or diet in adipose tissue ACE2. Additionally, the potential implications of these effects on COVID-19 are also addressed. The results published show that diet and obesity are two factors that effectively influence the expression of Ace2 gene in adipose tissue. However, the shifts in this gene do not always occur in the same direction, nor with the same intensity. Additionally, there is no consensus regarding the implications of increased adipose tissue ACE2 expression in health. Thus, while in some studies a protective role is attributed to ACE2 overexpression, other studies suggest otherwise. Similarly, there is much debate regarding the role played by ACE2 in COVID-19 in terms of degree of infection and disease outcomes. The greater risk of infection that may hypothetically derive from enhanced ACE2 expression is not clear since the functionality of the enzyme seems to be as important as the abundance. Thus, the greater abundance of ACE2 in adipose tissue of obese subjects may be counterbalanced by its lower activation. In addition, a protective role of ACE2 overexpression has also been suggested, associated with the increase in anti-inflammatory factors that it may produce.